Dr. Camprodon is Chief of the Division of Neuropsychiatry and Neuromodulation and director of the Laboratory for Neuropsychiatry and Neuromodulation at Massachusetts General Hospital, and Assistant Professor of Psychiatry at Harvard Medical School. Clinically, he is the founding director of the MGH Transcranial Magnetic Stimulation (TMS) clinical service, a member of the Psychiatric Neurosurgery Committee and an attending physician in the departments of Psychiatry (Neuropsychiatry) and Neurology (Cognitive and Behavioral Neurology). He is board-certified in Psychiatry and Behavioral Neurology-Neuropsychiatry. Dr. Camprodon’s practice focuses on Neuropsychiatry and Behavioral Neurology, working clinically across the Departments of Psychiatry and Neurology at MGH. Using an integrated clinical neuroscience model, he cares for patients with comorbid neurological and psychiatric disorders, or presenting with atypical syndromes including disordered cognition, behavior and/or emotion in the context of known or suspected brain pathology. Dr. Camprodon’s clinical and research work focuses on Interventional Neuromodulation, using traditional and novel brain stimulation techniques such as Transcranial Magnetic Stimulation (TMS), Transcranial Direct Current Stimulation (tDCS), Electroconvulsive Therapy (ECT), Vagus Nerve Stimulation (VNS) and Deep Brain Stimulation (DBS). Research in his laboratory uses multimodal combinations of neuroimaging and brain stimulation to investigate neural circuitry and plasticity in a translational manner. He is interested in understanding basic circuit properties of human neural networks and how maladaptive plastic changes lead to neuropsychiatric disorders. Critical efforts, central to his role as a clinician-scientist, are geared toward applying the paradigms and methods of basic systems neuroscience to develop high-impact clinical tools, identify targets for therapeutic action and design individualized image-guided neuromodulation treatments. Dr. Camprodon studied Philosophy and Medicine at the University of Barcelona. After a neuroimaging research fellowship in the Department of Neurology at the Humboldt University in Berlin (Germany), he moved to Boston to pursue a PhD in Neuroscience in the Department of Neurology at Beth Israel Deaconess Medical Center, and a Master’s in Public Health at the Harvard School of Public Health. After completing his scientific training, he continued his research as junior faculty in the Department of Neurology at Harvard, until he joined MGH to do a Psychiatry residency, be the chief resident of the MGH Psychiatric Consultation Service and complete a clinical fellowship in Behavioral Neurology and Neuropsychiatry.
Dr. Barbour is the Medical Director of the Massachusetts General Hospital Transcranial Magnetic Stimulation (TMS) clinical service, and an attending physician in the Department of Psychiatry. Dr. Barbour practices psychiatry by focusing on the individual and their unique strengths to deliver highly individualized care by utilizing her experience in psychotherapy, clinical neuroscience, and mind-body medicine to treat patients with multiple mental and physical comorbidities. Dr. Barbour’s research interests focus on addressing ways of improving treatment outcomes using Transcranial Magnetic Stimulation (TMS) through individualized treatment planning. Dr. Barbour received her medical degree from Wayne State University School of Medicine in Detroit, Michigan. After graduating from medical school, Dr. Barbour moved to Boston to join the combined Massachusetts General Hospital and McLean Hospital Adult Psychiatry Residency Program. During residency, she joined the program’s research track and served as the chief resident of McLean Hospital’s Clinical Evaluation Center. Following residency, Dr. Barbour was awarded the competitive Dupont-Warren Fellowship from Harvard Medical School, to learn advanced methods in neuroimaging and neuroscience research. Recently, Dr. Barbour was awarded a nationally prestigious NARSAD Young Investigator Award from the Brain and Behavior Foundation to study neuroimaging correlates of social behavior and social dysfunction.
Dr. Cassano is a researcher and a clinician. His work addresses inequality in brain health, which hampers people’s lives. He is interested in revolutionary interventions to treat and to prevent brain disorders. His focus is on the use of light (photobiomodulation with red and near-infrared light) to improve brain health. Near-infrared light is natural, as it represents one third of sunlight.
Brain disorders are just the tip of the iceberg. For all healthy people, who are fortunate not to experience symptoms of a brain disorder, the brain is still continuously under the wear and tear of life stressors and of aging. Prolonged stress affects our brain by leading to excessive inflammation and oxidation of the brain, as well as by decreasing brain energy and brain rejuvenation (also called neuroplasticity). Overtime, this cumulative brain damage is considered to predispose to brain disorders.
Among the new potential interventions, photobiomodulation with red and infrared light specifically targets the wear and tear of the brain and brings new hopes of improving or maintaining brain health.
His efforts, as a clinician and scientist, are focused on making this new intervention available to people, on studying its clinical applications and on guiding its optimal use.
Brain health is essential to mothers and fathers who want to decrease their chances of contracting a familial brain disease, such as dementia. Brain health is also important to daughters and sons who during puberty are more at risk of mood and anxiety disorders and of suicide. The lack of brain health is likely to affect all our relationships: in the couple, at home, at work and in life in general; therefore, altering the bonds, which make life meaningful.
By addressing their brain health, people might have an opportunity to blossom and to strive for what they believe in; possibly, to overturn an unfair script of their biology.
Dr. Ellard is the Director of Dimensional Neuroimaging Research in the Division of Neuropsychiatry and Neuromodulation at MGH. She completed her PhD in clinical psychology at Boston University under the mentorship of Dr. David Barlow, and completed her clinical internship and postdoctoral fellowship at Massachusetts General Hospital/Harvard Medical School. She was co-developer and co-author of the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders, a cognitive behavioral treatment designed to target emotion dysregulation across mood and anxiety disorders, which has now been translated into six languages. Dr. Ellard’s research uses transdiagnostic, dimension-based neuroscience and behavioral approaches to understand the roots of severe cognitive and affective dysregulation in neuropsychiatric disorders, and to find more efficient and effective means to address this dysregulation through combined behavioral and neuromodulatory approaches such as transcranial magnetic stimulation (TMS) and deep brain stimulation (DBS). She has received several foundation awards and two NIH National Research Service Awards for her research program (F31/F32), including most recently a Fellowship Award through the MGH and Brown University Joint Training Program in Recovery and Restoration of CNS Health and Function (T32) and a Mentored Patient-Oriented Career Development Award (K23) from the NIMH.
Her research program focuses on bridging neuroscience, transdiagnostic functional assessment and cognitive-behavioral therapy (CBT) approaches to improve patient outcomes in neuropsychiatric disorders, and particularly bipolar mood and anxiety disorders. A particular emphasis in her research is the effect of neurocircuit dysfunction associated with emotion regulation on the cognitive, emotional, and behavioral impairments experienced by individuals suffering these disorders. The overall aim of her research program is to push the field towards a neuro-rehabilitative model of intervention for severe psychopathology, wherein the synergistic combination of behaviorally and dimensionally informed neuromodulation and CBT can serve to improve both the capacity and the ability to successfully regulate bipolar mood and anxiety symptoms, thereby improving wellness and daily functioning. To accomplish this, Dr. Ellard have been systematically investigating 1) the neural bases of emotion and cognitive dysfunction in bipolar mood and anxiety disorders, and the relationship to CBT treatment response; 2) the efficacy of innovative emotion focused CBT interventions in addressing emotion and cognitive dysfunction in bipolar mood and anxiety disorders, and barriers to treatment response; and 3) the development of novel non-invasive neuromodulatory approaches that target and improve neurocircuit function implicated in emotion regulation. The future goals of her research program will be to test the neuro-rehabilitative model, by evaluating whether sequentially combining non-invasive neuromodulation (aimed at rehabilitating emotion regulation related neurocircuitry) with emotion focused CBT (aimed at learning and consolidating adaptive emotion reguation skills) can improve outcomes for severe bipolar mood and anxiety disorders.
Dr. Eldaief is a clinical neuroscientist interested in better understanding how maladaptive brain states, measured with resting-state functional connectivity, promote the manifestation of specific neuropsychiatric symptoms (e.g. apathy, anhedonia, anxiety, disinhibition). He is specifically interested in intrinsic corticolimbic networks anchored in prefrontal cortex and interconnected to regions involved in affective processing such as: amygdala, hippocampal formation, frontoinsular cortex, ventral and dorsal striatum, orbitofrontal and peri-genual cingulate cortex. Dr. Eldaief’s work investigates how these corticolimbic circuits dynamically change across timescales, with different processing demands, and in response to directed neuromodulation. To examine this, he has adopted multimodal experimental approaches which combine transcranial magnetic stimulation (TMS) with resting-state MRI and positron emission tomography (PET).
Dr. Eryilmaz is a cognitive neuroscientist and biomedical engineer. His research focuses on neural correlates of attention and working memory and the mechanisms by which they are impaired in psychopathology. His current project uses fMRI to identify the brain networks associated with working memory deficits in first-episode psychosis and leverages TMS to gauge plasticity of such deficits and obtain imaging predictors of recovery in the early phase of illness.
Dr. Jamil received his B.Sc in Biology at University of Maryland, College Park, his M.Sc in Neuroimaging at Kings College London (UK), and his Ph.D in Neuroscience at the University of Goettingen (Germany). He is currently a post-doctoral research fellow in the Laboratory of Neuropsychiatry and Neuromodulation. Asif’s research is focused on innovating and optimizing the design and application of non-invasive neuromodulation techniques such as TMS, tACS and tDCS for potential use in neuropsychiatric disorders. His doctoral and post-doctoral work, which combined neuromodulation with neuroimaging techniques (e.g., EEG and fMRI), has advanced the mechanistic understanding of how non-invasive brain stimulation alters neurophysiology, neuroplasticity, and ultimately behavior and function.
Dr. Wade completed his PhD in bioengineering at the University of California, Los Angeles (UCLA), where he was mentored by Dr. Paul Thompson. His postdoctoral research continued at the Ahmanson-Lovelace Brain Mapping Center at UCLA with Dr. Katherine Narr and the University of Utah with Dr. David Tate. His work has been supported by several awards from the National Institute of Mental Health (K99/R00), the Brain & Behavior Research Foundation (NARSAD Young Investigator Award), and the National Science Foundation (GRFP). He is currently Assistant Professor at MGH and HMS.
Dr. Wade’s research is focused on developing statistical and machine learning models to identify biomarkers of antidepressant response using multimodal neuroimaging data. Motivated by the recognition that symptoms of mood disorders are heterogenous both within and across classically-defined diagnostic boundaries, his work also focuses on the development of diagnostic biomarkers to detect the presence of transdiagnostic symptom disturbances. Data-driven methods hold great promise for the development of more personalized treatment strategies. His work aims to leverage these methods to jointly contend with symptomatic heterogeneity of mood disorders and identify robust biomarkers to improve prognostic and diagnostic precision in psychiatry.
Dr. Ning received his Ph.D. in Electrical and Computer Engineering from the University of Minnesota. His research interests lie in developing computational algorithms for joint analysis of structural and functional brain networks using diffusion and functional MRI. He is also interested in developing super-resolution and multi-dimensional neuroimaging techniques to investigate the microstructure of brain tissue. His clinical research focus is on applying novel neuroimaging techniques to understand the mechanism and target engagement of neuromodulation therapies including transcranial magnetic stimulation (TMS), electroconvulsive therapy (ECT). Dr. Ning is also affiliated with the Psychiatry Neuroimaging Laboratory at Brigham and Women’s Hospital.
Dr. Kritzer-Cheren received his MD and PhD from the University of Miami Miller School of Medicine. He completed his psychiatry residency at Duke University and his fellowship in Behavioral Neurology and Neuropsychiatry at Massachusetts General Hospital. He is an Instructor at Harvard Medical School and is an attending physician in Neuropsychiatry, Transcranial Magnetic Stimulation and the Acute Psychiatric Service. He is also a Research Fellow through the Psychiatry Department’s Translational Neuroscience Training for Clinicians T32 investigating neurocircuit-based mechanisms of the lateral septum’s role in motivated behavior after stress and with neuromodulation.
Dr. Santarnecchi is an Associate Professor of Radiology at Associate Professor of Psychiatry at Harvard Medical School, and the director of the Precision Neuroscience & Neuromodulation program (PNN) and the Network Control Laboratory at the Gordon Center for Medical Imaging at Massachusetts General Hospital (MGH).
Dr. Santarnecchi’s program focuses on combining multimodal neuroimaging (e.g., MRI, fMRI, DTI, PET) and electrophysiology (e.g., EEG, EMG, MEG) methods for the identification of novel diagnostic/prognostic biomarkers and the development of therapeutic approaches for patients with neurological and psychiatric conditions. In particular, Dr. Santarnecchi’s research is centered around the development of personalized, network-based Noninvasive Brain Stimulation (NiBS) approaches to modulate brain plasticity, guide connectome rewiring, boost resilience and enhance cognitive function and reserve, with the ultimate goal of promoting brain health and healthy aging. His team is currently working on machine/deep learning solutions for perturbation-based brain connectivity analysis (e.g., TMS-EEG), NIBS approaches to modulate sleep and memory, high-frequency transcranial alternating current stimulation (tACS) interventions for the treatment of Alzheimer’s disease and Frontotemporal dementia, and novel fMRI-based markers of disease progression in patients with brain tumors. His work on brain health also includes studies on space physiology in collaboration with NASA, for the development of potential countermeasures to maintain optimal brain performance in extreme environments including spaceflight. Dr. Santarnecchi also holds a Clinical Psychology and Neuropsychology degree and a Psy.D. in Cognitive Behavioral Therapy; his team is investigating how to combine brain connectomics and noninvasive brain stimulation to maximize the effect of psychotherapy by increasing brain plasticity or by consolidating clinical effects during sleep.
Dr. Hadimani an Associate Professor and the Director of the Biomagnetics Laboratory at the Department of Mechanical and Nuclear Engineering of Virginia Commonwealth University. He is currently on sabbatical as a Visiting Associate Professor at Harvard Medical School, Harvard University. He has founded the IEEE Joint Magnetics and Engineering in Medicine and Biology Society’s Richmond Chapter, and he is the current vice chair of the chapter. He is an Associate Editor of the journals, Frontiers of Neuroscience and American Institute of Physics (AIP) Advances.
Dr. Hadimani’s research focuses on biomagnetic materials and devices for biomedical applications. He has developed a first-of-a-kind anatomically accurate brain phantom for validating neuromodulation procedures that are commercialized through the university spin-off company RAM Phantoms LLC. His lab has designed and fabricated a novel focal stimulation coil using ferromagnetic cores that can stimulate only a local region of the primary motor cortex of small animals. He is currently working to experimentally verify the results from coil design in rats. He is also working to establish an accurate mechanism underlying TMS by investigating the neuron’s firing patterns in several regions of the brain induced by cortical stimulation and by establishing the role of individual nuclei in affecting other nuclei of the motor circuitry. This will enable the future development of effective TMS protocols for the diagnosis and treatment of several neurological and psychiatric disorders.
Dr. Hadimani has received several international awards, including the UK Energy Innovation Award and the International Young Scientist Fellowship from the National Natural Science Foundation of China (NSFC). He also received the Engineer of the Year award from the Richmond Joint Engineers’ Council in 2021. He has authored more than 100 peer-reviewed original research papers, more than 210 international conference papers, 12 current and pending patents, several invited trade magazine articles, a book, and 3 book chapters to date. Dr. Hadimani has a ‘first class’ honors degree in Mechanical Engineering from Kuvempu University, India, an MS in Mechatronics from the University of Newcastle, UK, and a Ph.D. in Electrical Engineering from Cardiff University, UK. He has served as a Project Scientist at the Institute of Materials Research and Innovation of the University of Bolton, UK. He was an Adjunct Assistant Professor and Associate Scientist at Iowa State University and was also an Associate at Ames Laboratory, US Dept. of Energy.
Dr. Rivas-Grajales is an Assistant Professor in the Department of Psychiatry at Boston University School of Medicine and Director of Neuropsychiatry and Neuromodulation at Boston Medical Center. Dr. Rivas-Grajales completed residency training in psychiatry at Baylor College of Medicine and a clinical fellowship in Behavioral Neurology and Neuropsychiatry at Massachusetts General Hospital in June 2022. Her research focuses on the understanding of the mechanism of action of neuromodulation therapies for treatment-resistant depression, and in identifying clinical and imaging biomarkers of rapid-acting antidepressants.
Christopher received dual B.S. degrees in Medical Biology and Health Psychology from MCPHS in 2015. He then received an M.S. degree in Physiology and Biophysics from Georgetown University in 2016, and an M.B.A. degree in Healthcare Management from MCPHS in 2022. Chris joined MGH in 2016 as part of the Integrated Brain Health Clinical and Research Program with Dr. Ana-Maria Vranceanu. In his role, he coordinated studies developing telehealth-based behavioral treatments for patients with physical and psychiatric comorbidities. In 2018, he joined the Laboratory of Neuropsychiatry and Neuromodulation with Dr. Joan Camprodon. In his role, he coordinated neuroimaging studies investigating biomarkers and predictors of response to neuromodulation treatments. Additionally, he treated patients in the Transcranial Magnetic Stimulation Clinical Service. As of 2021, Chris has been working as the Program Manager for the Division of Neuropsychiatry and Neuromodulation. In his role, he oversees all administrative, clinical, research, and educational operations of the division. Chris is interested in the intersection of mental health and technology with emphasis on improving accessibility to neuropsychiatric treatments in underserved and disadvantaged populations.
Jessenia graduated from University of Massachusetts Boston in 2016 with a B.A in Psychology. Jessenia has been at Massachusetts General Hospital since 2016. She previously worked as a patient service coordinator at the Electroconvulsive Therapy (ECT) clinic in the department of Psychiatry. In 2018, Jessenia joined the TMS Clinical Service in the Division of Neuropsychiatry and Neuromodulation as the Program Coordinator.
Dr. Cho is a clinical fellow in Interventional Neuropsychiatry and Neuromodulation in Department of Psychiatry at the Massachusetts General Hospital. Dr. Yoonju Cho began her training at Johns Hopkins University, where she received PhD in biomedical engineering studying sensory perception on human subjects as well as animal models. Then, she joined NYU Grossman School of Medicine for accelerated MD-residency training, where she fast-tracked into residency in psychiatry with focus on developing engineering solutions to clinical questions. Dr. Cho’s current clinical and research interests include advancing and integrating neurostimulation treatment methods such as electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS), and transcranial photobiomodulation (tPBM).
Dr. Praschan is a clinical fellow in the Behavioral Neurology and Neuropsychiatry Fellowship at the Massachusetts General Hospital (2023). He is board-certified in psychiatry and trained at Massachusetts General Hospital and McLean Hospital where he was the chief resident (2021). He has also completed a fellowship in consultation-liaison psychiatry at Brigham and Women’s Hospital (2022). He is most interested in disorders at the interface of neurology and psychiatry, including movement disorders and catatonia, neurodegenerative diseases, and functional neurological disorders.
Dr. Hurtado completed her medical training in Universidad del los Andes in Bogotá, Colombia. She was then recruited to investigate the use of several Neuromodulation techniques, like Transcranial Magnetic Stimulation, to treat chronic pain at Spaulding Rehabilitation Hospital, Harvard Medical School. She then looked to apply this experience to study novel applications of these techniques to the treatment and disentangle neuropsychiatric conditions. She is currently a post-doctoral research fellow in the Laboratory of Neuropsychiatry and Neuromodulation at the Massachusetts General Hospital and Harvard Medical School and is a part of the Photobiomodulation team. She is researching novel applications of transcranial Near-Infrared Light, like the modulation of connectivity of patients with Major Depressive Disorder or with Mild Cognitive Impairment.
Dr. Chowdhury is an applied physicist. She received her terminal degree in Physics from Duke University, Durham,NC. After her graduation, she worked as a research scientist at Xerox (Xerox Innovation Group, Webster,NY ) on printer based image processing. After the industry stint, she took a personal sabbatical to stay home with her two daughters. She returned to an academic career at the University of Massachusetts, Lowell via the M. Hildred Blewett fellowship from the American Physical Society. She is also the winner of the American Association of University Women (AAUW) American fellowship for the year 2020-2021.
Dr. Chowdhury has a breadth of research experience solving research problems in industrial and academic settings. She currently applies mathematical physics to problems at the intersection of physics, imaging and neuro-biology. Her interests involve creating and applying graph-theoretical algorithms, including machine learning/deep learning based algorithms to multimodality neuroimaging datasets in order to better understand neurological disorders.
Apart from research, she is interested in teaching undergraduate students. She has previously run tutoring practice teaching college level courses in mathematics and physics including pro-bono tutoring for community college students. She is keen on equitable distribution of education and teaches à linear algebra course every year at à local community college.
Dr. Evans is a research fellow within the Neuropsychiatry and Translational Research Fellowship (NeTReF) program at the VA Boston Healthcare System and Massachusetts General Hospital. His research broadly focuses on characterizing dysregulation within neural circuits that underly maladaptive social behavior across internalizing disorders. In this research, he examines how social reward and social threat modulate motivation to approach and avoid potential social interactions. Ultimately, he aims to integrate his research and clinical experiences to identify patient-level biomarkers that can be employed to guide treatment selection for internalizing disorders.
Dr. Cano initiated her collaboration with the Laboratory for Neuropsychiatry and Neuromodulation at the Massachusetts General Hospital-Harvard Medical School during her predoctoral training in Electroconvulsive Therapy for Treatment-Resistant Depression and Magnetic Resonance Imaging. She is currently a postdoctoral researcher at Sant Pau Biomedical Research Institute, where she is leading the Neuroimaging Lab of the Sant Pau Mental Health Research Group. However, her close collaboration with Dr. Camprodon during the last years evolved her research line and she is primarily focused on understanding the dimensional impact of rapid-acting antidepressants on patients with treatment-resistant depression with the final aim to develop a personalized prediction model of antidepressant treatment response
Dr. Vieira is a Research Fellow at the Massachusetts General Hospital (MGH) and Harvard Medical School (HMS), and a Post-Doctoral Researcher Scholar at the University of Sao Paulo (USP), Brazil. He is a Physical Therapist (PT) (2011), with a specialization (Latu Sensu) (2012) in Orthopaedic Traumatology Disorders. He attained a Master of Science (M.Sci.) (2014) in Electrical and Biomedical Engineering from the Department of Semiconductors, Instruments, and Photonics, at the School of Electrical and Computer Engineering (FEEC), University of Campinas (UNICAMP), Brazil. Dr. Vieira received his Ph.D. (2020) in Functional and Molecular Biology at the Institute of Biology (UNICAMP) and at the École Nationale Supérieure des Mines de Saint-Étienne (EMSE), Department of Bioelectronics, Centre Microélectronique de Provence, Provence-Alpes-Côte D’Azur, France. He is a member of the International Association for the Study of Pain (IASP), the Special Interest Group on Neuropathic Pain (NeuPSIG), and the Brazilian Society of Neurosciences and Behavior (SBNeC). Dr. Vieira is a guest editor for Frontiers in Pain Researchand for Photonics (MDPI), and a reviewer for >10 peer reviewed journals. He works mainly on the following topics: Low-Level Laser Therapy (LLLT)/Photobiomodulation Therapy (PBMT) and Transcranial Photobiomodulation (t-PBM); myonecrosis; gait biomechanics; spectroscopy of biomolecules (Raman and FT-IR); molecular biology; diabetic neuropathic pain; neurophysiology; mitochondrial metabolism; affective components of chronic pain; anxiety; and major depressive disorder (MDD).
Dr. Coelho is a Research Fellow in the Division of Neuropsychiatry and Neuromodulation at the Massachusetts General Hospital and Harvard Medical School. He pursued his medical training at Universidade Federal do Rio de Janeiro in Brazil and received honors cum laude. As a medical student, David participated in a project testing patients with schizophrenia for toxoplasmosis and compared their cognition. After graduation, he completed the Principles and Practice of Clinical Research course at Harvard T.H. Chan School of Public Health by Dr. Felipe Fregni and gained skills in statistical analyses. Planning to apply to psychiatry as a residency, David is currently working with Dr. Paolo Cassano in the field of photobiomodulation and has a strong interest in the treatment of mood disorders.
Dr. Lopez completed his medical training in the Universitat Autònoma de Barcelona, Spain (2012-2018). He is currently enrolled in the medical residency programme in psychiatry at Hospital Universitari de Bellvitge (2019-2023) and in the PhD Program in Neuroscience at Universitat de Barcelona (2022-present).
He is mainly interested in mood and anxiety related disorders and its impact and dysfunctionality in the long term. In this sense, he is a member of the Obsessive-Compulsive Disorder (OCD) Unit and the Treatment-Resistant Depression Unit of his department, where he has been given the opportunity to deepen his understanding of Electroconvulsive Therapy (ECT) and Deep Brain Stimulation (DBS).
Dr.Lopez has joined the Laboratory of Neuropsychiatry and Neuromodulation at the Massachusetts General Hospital and Harvard Medical School as a Graduate Student Research Fellow learning about Transcranial Magnetic Stimulation (TMS) and Transcranial Direct Current Stimulation (tDCS) in order to elucidate the possibilities and novel applications of these treatments in OCD and mood and anxiety disorders.
Chris graduated from Maastricht University (The Netherlands) with a B.S. in Psychology and Neuroscience in 2021. As an undergraduate student, Chris conducted a research project relating to the fields of attention and neuromodulation. After graduating, Chris continued studying at Maastricht University, pursuing a master’s degree in Cognitive Neuroscience. As part of this research-oriented study program, Chris has joined the Lab for Neuropsychiatry and Neuromodulation. In the position of Graduate Student Research Fellow, Chris aims to contribute to translational research that will help take insights into brain dynamics and disorders and use them to improve treatment for patients.
Anna received her Bachelor’s degree in psychology from University of Hamburg, Germany in 2011 and her Master’s degree in Social Cognition from University College London, UK in 2012. As an undergraduate she worked as a Research Assistant on intercultural differences of moral decision-making at University of Hamburg, and conducted behavioral and neuropsychological research (EEG) on the impact of social expectations on economic decision-making at University of Granada, Spain. For the past 7 years, she worked for different human rights organizations on land rights and indigenous rights in Brazil and Central America. Currently, Anna is a clinical research coordinator in the Laboratory of Neuropsychiatry and Neuromodulation, and provides treatment to patients in the TMS clinical service.
Astrid graduated from the University of Massachusetts Amherst with a bachelor’s in psychology. She then worked as a Research Assistant on a clinical research study at Brigham & Women’s Hospital. Astrid then went on to complete her master’s degree in Psychology at KULeuven, Belgium. During her graduate studies, Astrid’s work mainly investigated the biomarkers and the cognitive basis of Developmental Language Disorders (DLD) in efforts to implement timely diagnosis and early, effective intervention. She has since moved back to Boston to join the Division of Neuropsychiatry and Neuromodulation at the Massachusetts General Hospital where she assists in the Transcranial Magnetic Stimulation (TMS) Clinical Service, and performs various other research responsibilities in the lab.
James graduated from Northeastern University in Spring 2020 with his B.S. in behavioral neuroscience. During his undergraduate career, James was involved in both human and rodent research investigating topics such as sleep, memory, and cannabinoids. After graduating, James worked as a research associate in the Stanley Center for Psychiatric Research at the Broad Institute where he used ex vivo electrophysiology to study the genetic basis of schizophrenia and evaluate novel therapeutic compounds. Currently, James is a Clinical Research Coordinator in the Lab for Neuropsychiatry and Neuromodulation where he treats patients in the TMS Clinical Service and conducts research on the application of TMS for major psychiatric disorders. In his spare time, James enjoys outdoor activities in his home state of New Hampshire and playing board games with friends.
Nicole graduated from Ohio State University in May 2022 with a bachelor’s degree in psychology and minors in neuroscience and communications. As an undergraduate, she worked as a research assistant studying adolescent girls with ADHD, social motivation and how this impacts mental health, and mental health stigma and suicide completion reduction within three different experiences. She currently serves as a Clinical Research Coordinator at the Division of Neuropsychiatry and Neuromodulation at Massachusetts General Hospital. There, she treats patients in the Transcranial Magnetic Stimulation (TMS) Clinical Service and serves as a research coordinator of a research study in the lab.
Stephanie graduated cum laude from the University of Vermont in May of 2022, earning a Bachelor of Science in Psychological Science. In addition, she was designated as an Honors College Scholar after having completed an Honors Senior Thesis on the topic of workplace discrimination towards individuals with psychological disorders. For her thesis, she conducted independent research, reviewing the existing literature and utilizing relevant information to synthesize and original model for determining the likelihood of discrimination occurring in the workplace. Based on this new model, Stephanie proposed potential strategies for reducing discrimination and improving workplace conditions for individuals with psychological disorders.
Currently, Stephanie is working as a Clinical Research Coordination for the Division of Neuropsychiatry and Neuromodulation at the Massachusetts General Hospital and Harvard Medical School. In this role, Stephanie is involved in both clinical and research work. On the clinical side, she treats patients using Transcranial Magnetic Stimulation (TMS). On the research side, she will be involved in various research projects exploring the application of TMS and Transcranial Direct Current Stimulation (tDCS).
Zoe Ongaro graduated in 2020 from the George Washington University with a Bachelor of Science in Nutrition and minor in Dance. She then became a Clinical Research Coordinator at the MGH Food Allergy Center, where she studied the impact of food allergy on nutrition, growth and development in infants and toddlers. Zoe then worked as a medical assistant at the MGH Ketamine Clinic and MGH Dermatologic Surgery department. Zoe now works in the MGH Division of Neuropsychiatry and Neuromodulation, where she helps treat patients in the Transcranial Magnetic Stimulation (TMS) Clinical Service. Additionally, Zoe is currently working as a Medical Assistant at the MGH Ketamine Clinic and MGH Dermatologic Surgery department. In her spare time, Zoe loves spending with her puppy, exploring restaurants in Boston, and bird watching.
Maia graduated from the University of Michigan in 2017 with a B.S. in Biopsychology, Cognition, and Neuroscience as well as Drama. As an undergraduate, she was a research assistant in the Michigan Psychoneuroendocrinology Affective Laboratory under the direction of Dr. Nestor Lopez-Duran studying the development of depression in adolescents with a familial history of major depressive disorder. Currently, Maia works as a clinical research coordinator at the Laboratory of Neuropsychiatry and Neuromodulation, where she coordinates photobiomodulation studies in depression, mild cognitive impairment, and Down Syndrome. Before joining the team, Maia worked as a performer at Walt Disney World. Outside of research, Maia’s passions include singing and acting. She plans to pursue a PhD in clinical psychology.
Alexandra graduated from Manhattan College in the Spring of 2022 with a B.S. in Mathematics and Psychology. During her undergraduate career, Alexandra conducted research in the mathematics of medical imaging focusing on accelerating and optimizing MRI. Additionally, she was involved in psychological research investigating the importance of using a culturally specific and validated measure to assess resilience among a population of Sri Lankan war survivors. Currently, Alexandra is a clinical research coordinator in the Division of Neuropsychiatry and Neuromodulation where she conducts research on the application of neuromodulation techniques like TMS and tDCS to improve outcomes in patients with neuropsychiatric disorders. In her free time, Alexandra enjoys spending time with her sisters, baking, and drinking lots of coffee.
Jackson is an undergraduate student at Indiana University, double majoring in chemistry and neuroscience with a minor in mathematics. As an undergraduate, he holds radiographic licensure for imaging of the skull, paranasal sinuses, and the craniomaxillofacial regions. Currently, Jackson is a research assistant at the Indiana University Department of Speech, Hearing, and Language Sciences under Dr. Steven Lulich. He performs data and neuroimaging analysis using clinical measurements from magnetic resonance imaging and sonography. Jackson is also a research assistant at the Indiana University School of Dentistry, working with a mice model studying osteoclasts, osteoblasts, osteocytes, and kalirin under the direction of Dr. Angela Bruzzaniti.
Additionally, Jackson works as an oral and maxillofacial surgical assistant in Cincinnati, Ohio, and has research interests in dentistry and oral and maxillofacial surgery. Jackson desires to approach oral health from different perspectives to understand better the systematic processes and associated structures that lead to overall health, focusing on temporomandibular disorders and pain. With research at the forefront, he is thrilled to be an intern in the Division of Neuropsychiatry and Neuromodulation at Massachusetts General Hospital and Harvard Medical School. Outside of academics and research, Jackson enjoys playing the saxophone, hiking, and spending time with his family and pets.
Yashas is a high school senior from Chandler, Arizona, working as a remote intern with the Division of Neuropsychiatry and Neuromodulation. He is currently conducting research on brain activity and functional connectivity, focusing on analyzing different methods to create functional connectomes. His interests primarily lie in coding and the biosciences, and he hopes to study computer science in college.
Shana Birly is a graduate student at Harvard Medical School, majoring in Bioethics. She obtained her BSc at San Jose State University in Health Sciences and Psychology with a concentration in Health Professions. Shana is currently an intern in the Division of Neuropsychiatry and Neuromodulation assisting with photobiomodulation clinical trials, and a research fellow at HMS exploring the ethics of portable neuroimaging devices in diverse populations for the NIH BRAIN Initiative. Prior to HMS, Shana was a scientist in clinical development at Genentech, a San Francisco based biotech company. She also worked as a research associate for UCSF and UC Davis prior to transitioning to industry. Shana hopes to obtain her PhD in Neuroscience where she can apply her experience in drug development and background on expanding diversity in neuroscience research. Shana is originally from California and enjoys hiking and playing with her dogs, Scooter and Mr. Darcy.
Katie is an undergraduate student at Harvard College, majoring in neuroscience, global health and health policy. As an intern with the Division of Neuropsychiatry and Neuromodulation, she is completing her senior thesis on the neural network effects of ECT and TMS. Katie intends to pursue medicine and is broadly interested in neurology, mental wellbeing, and patient-centered care.
Dr. Khadka is a post-doctoral fellow at the Massachusetts General Hospital and Harvard Medical School. He received his BE (2014) and PhD (2020) in Biomedical Engineering from the City University of New York. His research has concentrated on non-invasive and invasive modalities of electrical stimulation on both human and animal, primarily focusing on computational studies to explain the experiment. Dr. Khadka has 10+ years of experience in bench-top electrode and device testing, in vitro invasive brain stimulation studies (SCS and DBS), human and small animal tDCS experiments, and computational modeling of brain and spinal cord stimulation. Moreover, Dr. Khadka also reviews for >10 peer reviewed neuromodulation journals and serves as a guest editor for Frontiers in Neuroergonomics journal. Currently, Dr. Khadka is involved more into clinical studies with non-invasive electrical stimulation that involve analysis of EMG data acquired during TMS and development of E-field models of ECT and TMS for healthy and disease brain. In addition, Dr. Khadka is also collaborating with Dr. Marom Bikson (PhD advisor) on projects such as Adaptive ECT model, Radiofrequency ablation of peripheral nerve for pain management, High-density SCS, and Neurocapillary-modulation.
Ira graduated from New York University with a major in Psychology and a minor in Chemistry in May of 2020. During her time as an undergraduate, she worked as a research assistant at the Lab for the Developing Mind at NYU under Dr. Moira Dillon researching developmental spatial cognition. Outside of school, she volunteered her time in Greece working with organizations focused on feeding and educating homeless and refugee populations. Currently, Ira works as a Clinical Research Coordinator at the Laboratory for Neuropsychiatry and Neuromodulation, and treats patients in the TMS clinical service. Ira plans to attend medical school and pursue a career as a psychiatrist. In her free time, she can be found roller skating or watching movies.
Alexis received a bachelor’s degrees in psychology and sociology from U.C. Berkeley in 2017. As an undergraduate she worked at U.C. San Francisco, conducting fMRI research examining self-regulation in veterans with traumatic brain injuries. After graduating, she moved to Boston to work in the Dystonia and Speech Motor Control Lab at Massachusetts Eye and Ear. There, Alexis conducted brain imaging studies investigating the pathophysiology of laryngeal dystonia, as well as research evaluating suicidal behavior in idiopathic dystonia. She currently helps operate the Transcranial Magnetic Stimulation (TMS) Clinical Service as a member of the Laboratory for Neuropsychiatry and Neuromodulation at Massachusetts General Hospital. She plans to pursue a PhD in clinical neuropsychology.
Blake graduated from Vanderbilt University in May 2019 with a degree in cognitive neuroscience. During his undergraduate career, Blake worked as a Research Assistant in the Computational Memory Lab under the direction of Dr. Sean Polyn. Blake also volunteered as an Emergency Medical Technician for Vanderbilt LifeFlight, providing first-aid at local events throughout Nashville. Currently, Blake is a Clinical Research Coordinator at the Laboratory for Neuropsychiatry and Neuromodulation where he treats patients in the TMS clinical service while researching ways to optimize the treatment for future patients. In his spare time, Blake enjoys playing music, studying Japanese, and rock climbing.
Sofia graduated from Boston University in May 2017 with a dual degree in psychology and neuroscience. As an undergraduate, she interned at the Center for Autism Research Excellence (CARE) using EEG to investigate the brain systems underlying sound processing in children with autism. As a clinical research coordinator in the Laboratory of Neuromodulation and Neuropsychiatry, she coordinates neuroimaging studies exploring the biomarkers and the mechanism of action of TMS in patients diagnosed with Major Depressive Disorder and Bipolar Disorder. She also assists in providing TMS treatment in the MGH TMS Clinical Service. Sofi is currently pursuing her PhD in Clinical Psychology.
Dr. Homayoun attended University College London for her undergraduate studies and University of Birmingham in the UK for her Medical Degree. She completed her clinical training in Child and Adolescent Psychiatry at the Maudsley Hospital in London and is a member of the Royal College of Psychiatrists in the UK. She was formerly a post-doctoral research fellow in the Laboratory of Neuropsychiatry and Neuromodulation.